Extensive cutaneous metastases of ovarian cancer after prolonged response to liposomal doxorubicin

Highlights • Cutaneous metastases are rare and clinically challenging to manage. When present, they often represent end-stage disease. • Treatments for cutaneous metastases are limited, and primarily palliative in nature.

Saved in:
Bibliographic Details
Published inGynecologic oncology case reports Vol. 5; pp. 64 - 66
Main Authors Craig, Christine D, Iglesias, David A, Watkins, Jack, Coleman, Robert L, Kilgore, Larry, Ramirez, Pedro T
Format Journal Article
LanguageEnglish
Published Netherlands Elsevier Inc 2013
Elsevier
Subjects
Case Report
Hematology, Oncology and Palliative Medicine
Liposomal doxorubicin
Obstetrics and Gynecology
Ovarian cancer
Skin recurrence
Liposomal doxorubicin
Skin recurrence
Ovarian cancer
Online AccessGet full text

Cover

More Information
Summary:Highlights • Cutaneous metastases are rare and clinically challenging to manage. When present, they often represent end-stage disease. • Treatments for cutaneous metastases are limited, and primarily palliative in nature.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:2211-338X
2211-338X
DOI:10.1016/j.gynor.2013.05.005